HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sonia Alix Selected Research

PI 540

7/2009Biological properties of potent inhibitors of class I phosphatidylinositide 3-kinases: from PI-103 through PI-540, PI-620 to the oral agent GDC-0941.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sonia Alix Research Topics

Disease

3Neoplasms (Cancer)
07/2009 - 06/2007
1Malnutrition (Nutritional Deficiencies)
12/2009
1Glioblastoma (Glioblastoma Multiforme)
07/2009
1Ovarian Neoplasms (Ovarian Cancer)
06/2007
1Glioma (Gliomas)
06/2007

Drug/Important Bio-Agent (IBA)

2PI103IBA
07/2009 - 06/2007
22- (1H- indazol- 4- yl)- 6- (4- methanesulfonylpiperazin- 1- ylmethyl)- 4- morpholin- 4- ylthieno(3,2- d)pyrimidineIBA
07/2009 - 09/2008
111-beta-Hydroxysteroid Dehydrogenases (11beta Hydroxysteroid Dehydrogenase)IBA
12/2009
1Protein Isoforms (Isoforms)IBA
07/2009
1PI 540IBA
07/2009
1PI 620IBA
07/2009
1pyrimidineIBA
09/2008
1Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA
09/2008
1Biomarkers (Surrogate Marker)IBA
06/2007
1Biological ProductsIBA
06/2007
1Pharmaceutical PreparationsIBA
06/2007
1LipidsIBA
06/2007

Therapy/Procedure

1Therapeutics
06/2007